Table 2.
PRSgene | PRSintergenic | PRSall | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Population | Target dataset | Beta | SE | P-value | # Variants | Beta | SE | P-value | # Variants | Beta | SE | P-value | # Variants |
AA | Alla | 0.17 | 0.03 | 3.55E−08 | 858 | 0.03 | 0.03 | 0.32 | 675 | 0.12 | 0.03 | 9.42E−05 | 1,126,428 |
COGA | 0.15 | 0.04 | 9.67E−04 | 858 | 0.02 | 0.04 | 0.61 | 675 | 0.06 | 0.04 | 0.16 | 1,126,428 | |
SAGE | 0.18 | 0.07 | 6.27E−03 | 858 | 0.12 | 0.07 | 0.10 | 675 | 0.18 | 0.07 | 0.01 | 1,126,428 | |
YalePenn | 0.21 | 0.05 | 7.61E−05 | 858 | −0.02 | 0.06 | 0.76 | 675 | 0.17 | 0.06 | 7.28E−03 | 1,126,428 | |
EA | Indiana Biobank | 0.11 | 0.05 | 0.02 | 847 | 0.02 | 0.05 | 0.59 | 666 | 0.34 | 0.05 | 2.35E−21 | 1,061,130 |
Significant P-values are in bold.
PRSgene PRS calculated using concordant variants located in genes associated with AUD in both AA and EA, PRSintergenic PRS calculated using concordant variants located outside genes associated with AUD in both AA and EA, PRSall PRS calculated using all variants.
aCOGA, SAGE, and YalePenn combined.